{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:00:40Z","timestamp":1787929240624,"version":"build-2784847793"},"reference-count":11,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ejca.2005.02.026","type":"journal-article","created":{"date-parts":[[2005,5,25]],"date-time":"2005-05-25T12:41:42Z","timestamp":1117024902000},"page":"1300-1303","source":"Crossref","is-referenced-by-count":25,"title":["Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Gertjan J.L.","family":"Kaspers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle J.M.","family":"Wijnands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loekie","family":"Huismans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"Stackelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Henze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robrecht","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"H\u00e4hlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth R.","family":"Van Wering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjo J.P.","family":"Veerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2005.02.026_bib1","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V78.5.1166.bloodjournal7851166","article-title":"Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group","volume":"78","author":"Henze","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.02.026_bib2","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/sj.leu.2401938","article-title":"Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude children\u2019s research hospital","volume":"14","author":"Pui","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.02.026_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/978-3-642-19022-3_16","article-title":"Clinical significance of cellular drug resistance in childhood leukemia","volume":"161","author":"Kaspers","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.ejca.2005.02.026_bib4","first-page":"219","article-title":"In vitro chemosensitivity of lymphoblasts at relapse in childhood leukemia using the MTT assay","volume":"54","author":"Hongo","year":"1991","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ejca.2005.02.026_bib5","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood.V86.10.3861.bloodjournal86103861","article-title":"Cellular drug resistance in children with relapsed and refractory acute lymphoblastic leukemia","volume":"86","author":"Klumper","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.02.026_bib6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/sj.leu.2401129","article-title":"Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia \u2013 implications for treatment of infants","volume":"12","author":"Pieters","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2005.02.026_bib7","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V90.7.2723","article-title":"In vitro cellular drug resistance and prognosis in childhood acute lymphoblastic leukemia","volume":"90","author":"Kaspers","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.02.026_bib8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/bjc.1994.446","article-title":"Mononuclear cells contaminating leukemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay","volume":"70","author":"Kaspers","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.02.026_bib9","first-page":"268","article-title":"Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, l-asparaginase, and vincristine in childhood acute lymphoblastic leukemia","volume":"70","author":"Hongo","year":"1999","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ejca.2005.02.026_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2141.2003.04442.x","article-title":"Nordic Society for Paediatric Haematology and Oncology. Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia","volume":"122","author":"Frost","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.02.026_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2004.99.274","article-title":"Is the in vitro drug resistance profile the strongest prognostic factor in childhood acute lymphoblastic leukemia","volume":"22","author":"Styczynski","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905002157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905002157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T12:03:08Z","timestamp":1586260988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804905002157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0959804905002157"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2005.02.026","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}